Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 3.51% is 37% below its 5-year average of 5.57%, near the low end of its 5-year range (1.90%–17.94%).
As of the fiscal period ended Tuesday, June 30, 2026. 38.00% below its 12-month average of 5.66%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 3.51%.
RETURN ON EQUITY (ROE)
3.51%
RETURN ON EQUITY (ROE) AVG TTM
5.66%
RETURN ON EQUITY (ROE) AVG 3Y
6.54%
RETURN ON EQUITY (ROE) AVG 5Y
5.57%
RETURN ON EQUITY (ROE) AVG 10Y
14.72%
RETURN ON EQUITY (ROE) AVG 15Y
14.21%
RETURN ON EQUITY (ROE) AVG 20Y
14.36%
CURRENT VS TTM AVG
-38.00%
CURRENT VS 3Y AVG
-46.41%
CURRENT VS 5Y AVG
-37.00%
CURRENT VS 10Y AVG
-76.17%
CURRENT VS 15Y AVG
-75.33%
CURRENT VS 20Y AVG
-75.58%
SECTOR MEDIAN · HEALTHCARE
11.20%
median of 94 covered companies
CURRENT VS SECTOR MEDIAN
-68.69%
vs the sector median at left
ICON Public Limited Company
Market Cap
$12.41B
Return on Equity (ROE)
3.51%
TTM Avg
5.66%
3Y Avg
6.54%
5Y Avg
5.57%
Market Cap
$12.51B
Return on Equity (ROE)
10.49%
TTM Avg
6.83%
3Y Avg
5.29%
5Y Avg
3.21%
Market Cap
$12.14B
Return on Equity (ROE)
-17.13%
TTM Avg
-12.46%
3Y Avg
-8.76%
5Y Avg
-1.37%
Market Cap
$11.88B
Return on Equity (ROE)
23.91%
TTM Avg
22.63%
3Y Avg
21.83%
5Y Avg
21.13%
Market Cap
$11.47B
Return on Equity (ROE)
N/A
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$13.43B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
Market Cap
$11.34B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$11.10B
Return on Equity (ROE)
6.85%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
Market Cap
$13.98B
Return on Equity (ROE)
-8.40%
TTM Avg
-2.13%
3Y Avg
6.32%
5Y Avg
9.65%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICON Public Limited Company (ICLR) | $12.41B | 3.51% | 5.66% | 6.54% | 5.57% |
| Penumbra, Inc. (PEN)vs › | $12.51B | 10.49% | 6.83% | 5.29% | 3.21% |
| Baxter International Inc. (BAX)vs › | $12.14B | -17.13% | -12.46% | -8.76% | -1.37% |
| Encompass Health Corporation (EHC)vs › | $11.88B | 23.91% | 22.63% | 21.83% | 21.13% |
| DaVita Inc. (DVA)vs › | $11.47B | N/A | 329.18% | 200.63% | 164.66% |
| Tempus AI, Inc. (TEM)vs › | $13.43B | -57.18% | -651.33% | -315.37% | -198.08% |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 8.63% | 6.23% | 8.78% | 10.01% |
| The Cooper Companies, Inc. (COO)vs › | $11.10B | 6.85% | 4.70% | 4.67% | 11.22% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.98B | -8.40% | -2.13% | 6.32% | 9.65% |
| Universal Health Services, Inc. (UHS)vs › | $10.64B | 20.31% | 18.80% | 15.17% | 15.31% |
ROE
3.5%
ROA
2.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 3.51% |
| 2026-03-31 | 4.72% |
| 2025-12-31 | 5.32% |
| 2025-09-30 | 6.42% |
| 2025-06-30 | 8.31% |
| 2025-03-31 | 7.98% |
| 2024-12-31 | 8.31% |
| 2024-09-30 | 7.65% |
| 2024-06-30 | 7.45% |
| 2024-03-31 | 7.24% |
| 2023-12-31 | 6.63% |
| 2023-09-30 | 5.73% |
| 2023-06-30 | 5.80% |
| 2023-03-31 | 5.89% |
| 2022-12-31 | 5.95% |
| 2022-09-30 | 5.64% |
| 2022-06-30 | 2.58% |
| 2022-03-31 | 2.08% |
| 2021-12-31 | 1.90% |
| 2021-09-30 | 2.23% |
| 2021-06-30 | 17.94% |
| 2021-03-31 | 17.46% |
| 2020-12-31 | 17.96% |
| 2020-09-30 | 19.29% |
| 2020-06-30 | 21.11% |
| 2020-03-31 | 24.93% |
| 2019-12-31 | 23.11% |
| 2019-09-30 | 24.17% |
| 2019-06-30 | 23.59% |
| 2019-03-31 | 23.40% |
| 2018-12-31 | 23.82% |
| 2018-09-30 | 22.90% |
| 2018-06-30 | 23.83% |
| 2018-03-31 | 23.92% |
| 2017-12-31 | 23.63% |
| 2017-09-30 | 25.24% |
| 2017-06-30 | 26.65% |
| 2017-03-31 | 28.65% |
| 2016-12-31 | 27.74% |
| 2016-09-30 | 25.34% |
| 2016-06-30 | 27.36% |
| 2016-03-31 | 29.22% |
| 2015-12-31 | 31.33% |
| 2015-09-30 | 25.62% |
| 2015-06-30 | 20.54% |
| 2015-03-31 | 19.23% |
| 2014-12-31 | 18.15% |
| 2014-09-30 | 15.90% |
| 2014-06-30 | 13.85% |
| 2014-03-31 | 12.49% |
| 2013-12-31 | 11.29% |
| 2013-09-30 | 10.54% |
| 2013-06-30 | 9.98% |
| 2013-03-31 | 8.53% |
| 2012-12-31 | 7.34% |
| 2012-09-30 | 5.39% |
| 2012-06-30 | 2.69% |
| 2012-03-31 | 3.35% |
| 2011-12-31 | 3.36% |
| 2011-09-30 | 5.86% |
| 2011-06-30 | 8.91% |
| 2011-03-31 | 10.56% |
| 2010-12-31 | 13.00% |
| 2010-09-30 | 14.81% |
| 2010-06-30 | 16.17% |
| 2010-03-31 | 16.33% |
| 2009-12-31 | 16.48% |
| 2009-09-30 | 15.61% |
| 2009-06-30 | 16.12% |
| 2009-03-31 | 17.32% |
| 2008-12-31 | 17.12% |
| 2008-09-30 | 16.14% |
| 2008-06-30 | 14.78% |
| 2008-03-31 | 14.39% |
| 2007-12-31 | 14.41% |
| 2007-09-30 | 14.29% |
| 2007-06-30 | 13.94% |
| 2007-03-31 | 13.45% |
| 2006-12-31 | 12.65% |
| 2005-11-30 | 5.69% |
| 2005-08-31 | 5.29% |
| 2005-05-31 | 5.81% |
| 2005-02-28 | 6.41% |
| 2004-11-30 | 11.43% |
| 2004-08-31 | 12.34% |
| 2004-05-31 | 11.88% |
| 2004-02-29 | 11.50% |
| 2003-11-30 | 11.13% |
| 2003-08-31 | 11.01% |
| 2003-05-31 | 13.35% |
